Open AccessEffect of Duration and Intermittency of Rifampin on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis
Author(s) -
Dick Menzies,
Andrea Benedetti,
Anita Paydar,
Ian Martin,
Sarah Royce,
Madhukar Pai,
Andrew Ver,
Christian Lienhardt,
William J. Burman
Publication year - 2009
Publication title -
plos medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.847
H-Index - 228
eISSN - 1549-1676
pISSN - 1549-1277
DOI - 10.1371/journal.pmed.1000146
Subject(s) - medicine , tuberculosis , meta analysis , isoniazid , drug resistance , randomized controlled trial , relative risk , clinical trial , confidence interval , pathology , biology , microbiology and biotechnology
In a systematic review of randomized controlled trials on tuberculosis treatment, Dick Menzies and colleagues find shorter courses of rifampin to be associated with poorer treatment outcomes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom